Results 91 to 100 of about 8,618 (210)
IL‐33 Elicits LTC4 Synthesis in Allergic Inflammation via ST2‐Mediated Activation of Eosinophils
Allergic reaction‐derived IL‐33 activates ST2 to trigger selective eosinophil activation. IL‐33 in a type 2 immune response environment induces biogenesis of lipid bodies in eosinophils, platforms for the generation of lipid mediators, and selectively triggers LTC4 production.
Vitória F. Rosário‐Garcia +11 more
wiley +1 more source
Are soluble ST2 levels influenced by vitamin D and/or the seasons?
Objective: Cardiovascular disease manifestation and several associated surrogate markers, such as vitamin D, have shown substantial seasonal variation.
Vito Francic +15 more
doaj +1 more source
Cardiac disease in systemic sclerosis: Integrating pathobiology with clinical management
Abstract Systemic sclerosis (SSc) is a complex autoimmune disorder in which cardiovascular involvement remains a major determinant of morbidity and mortality. Cardiac injury in SSc results from the interplay of microvascular dysfunction, immune‐mediated inflammation, and progressive interstitial and replacement fibrosis, leading to myocardial disease ...
Henry Sutanto, Betty Rachma, Yuliasih
wiley +1 more source
ST2 and IL-33 in pregnancy and pre-eclampsia. [PDF]
Normal pregnancy is associated with a mild systemic inflammatory response and an immune bias towards type 2 cytokine production, whereas pre-eclampsia is characterized by a more intense inflammatory response, associated with endothelial dysfunction and a
Ingrid Granne +6 more
doaj +1 more source
Deletion of ASAH2 in intestinal epithelial cells induces the accumulation of ganglioside GD3 via regulating ST8SIA1. GD3 is identified as the glycolipid ligand for the inhibitory receptor Siglec‐E on macrophages. GD3/Siglec‐E ligation polarizes macrophages and promotes the proliferation of colonic ST2+ T regulatory cells via the induction of IL‐33. The
Zhishan Xu +11 more
wiley +1 more source
Cardiovascular biomarkers and preeclampsia: A narrative review
Preeclampsia (PE) is a complex pregnancy disorder linked to cardiovascular disease (CVD) through shared risk factors and epidemiological associations. Cardiovascular biomarkers are valuable for predicting, diagnosing and assessing PE, as well as estimating future CVD risk. This review explores current cardiovascular biomarkers used in clinical practice
Johana Ullmo +8 more
wiley +1 more source
Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
Aim Soluble suppression of tumorigenicity‐2 (sST2) is a strong prognostic biomarker in heart failure. The emerging understanding of circadian biology in cardiovascular disease may lead to novel applications in prognosis and diagnosis and may provide ...
Sandra Crnko +14 more
doaj +1 more source
This study develops the mean vertical additional stress coefficient on the basis of vertical additional stress, and an analytical solution for calculating the settlement of pile foundations is derived accordingly. The method simplifies settlement calculations by simply layering the soil layers with different compression moduli, eliminating the need for
Heng Wang +2 more
wiley +1 more source
BackgroundSoluble ST2 (sST2), a marker of myocyte stretch and fibrosis, has prognostic value in many cardiovascular diseases. We hypothesized that sST2 levels are associated with incident heart failure (HF), including subtypes of preserved (HFpEF) and ...
Ravi H. Parikh +5 more
doaj +1 more source
Background Pulmonary embolism (PE) is a serious cardiovascular condition associated with a wide range of clinical outcomes, from mild symptoms to severe hemodynamic compromise. Existing biomarkers like D‐dimer and proBNP have limitations in specificity and do not fully capture the inflammatory and hemodynamic aspects of the disease. Soluble suppression
Ahmet Seyfeddin Gurbuz +3 more
wiley +1 more source

